3-iodobenzylguanidine has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berná, L; Carrió, I; Estorch, M; López-Pousa, J; Tabernero, J; Torres, G | 1 |
| Akle, CA; Bomanji, JB; Talbot, I; Wardle, DG | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Sarcoma
| Article | Year |
|---|---|
Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity.
Topics: 3-Iodobenzylguanidine; Adult; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Doxorubicin; Female; Gated Blood-Pool Imaging; Heart; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Organometallic Compounds; Osteosarcoma; Sarcoma; Stroke Volume; Sympatholytics; Time Factors | 1995 |
mIBG diagnosis and therapy in smooth muscle tumours of the small bowel.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Iodine Radioisotopes; Jejunal Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma | 1997 |